Patents Assigned to Euro-Celtique, S.A.
  • Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
    Publication number: 20070185146
    Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
    Type: Application
    Filed: June 8, 2005
    Publication date: August 9, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer, Petra Leyendecker
  • Opioids for the treatment of the restless leg syndrome
    Publication number: 20070185147
    Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).
    Type: Application
    Filed: June 1, 2005
    Publication date: August 9, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer, Karin Gawora
  • Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
    Publication number: 20070179169
    Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
    Type: Application
    Filed: March 29, 2007
    Publication date: August 2, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Robert Chapman, Lonn Rider, Qi Hong, Donald Kyle, Robert Kupper
  • Methods for detecting 14-hydroxy codeinone and codeinone
    Publication number: 20070172958
    Abstract: Disclosed is a method of detecting the presence of 14-hydroxycodeinone and/or codeinone in an oxycodone preparation.
    Type: Application
    Filed: March 30, 2005
    Publication date: July 26, 2007
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Bassam Freiha, John Decubellis
  • Aryl substituted pyrimidines and the use thereof
    Patent number: 7229993
    Abstract: This invention relates to a method of treating disorders responsive to the blockade of sodium ion channels using novel aryl-substituted pyrimidine compounds of Formula I: or a pharmaceutically acceptable salt, or solvate thereof, wherein A, R1, R2, R3 and R4 are defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: June 12, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: R. Richard Goehring, Sam F. Victory, Donald J. Kyle
  • Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
    Publication number: 20070117829
    Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
    Type: Application
    Filed: January 16, 2007
    Publication date: May 24, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Robert Chapman, Lonn Rider, Qi Hong, Donald Kyle, Robert Kupper
  • Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
    Publication number: 20070117831
    Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
    Type: Application
    Filed: January 16, 2007
    Publication date: May 24, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Robert Chapman, Lonn Rider, Qi Hong, Donald Kyle, Robert Kupper
  • Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
    Publication number: 20070117830
    Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
    Type: Application
    Filed: January 16, 2007
    Publication date: May 24, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Robert Chapman, Lonn Rider, Qi Hong, Donald Kyle, Robert Kupper
  • Pharmaceutical formulation
    Publication number: 20070098795
    Abstract: A solid, oral controlled release pharmaceutical dosage form has a water-soluble active ingredient dispersed in a matrix and releases the active ingredient at such a rate upon administration that the median tmax is 2.5 to 6 hours and the ratio of mean Cmax to mean plasma level of the active ingredient at 24 hours is in the range of 1.5 to 3.5.
    Type: Application
    Filed: December 18, 2006
    Publication date: May 3, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Ronald Brown Miller, Stewart Thomas Leslie, Santa Therese Antoinette Malkowska, Derek Allan Prater, Trevor John Knott, Hassan Mohammad
  • Therapeutic agents useful for treating pain
    Patent number: 7202259
    Abstract: 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound, methods for treating or preventing pain or diarrhea in an animal comprising administering to an animal in need thereof an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound and methods for stimulating opioid-receptor function in a cell comprising contacting a cell capable of expressing an opioid receptor with an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound are disclosed.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: April 10, 2007
    Assignee: Euro-Celtique S.A.
    Inventor: Zhengming Chen
  • COMPARTMENTALIZED DOSAGE FORM
    Publication number: 20070026068
    Abstract: The present invention provides a dosage form that prevents misuse of the medicament contained within. The dosage form contains an inactivating substance in combination with the medicament, wherein the two substances are separated by a permeable or semi-permeable partition. The partition becomes impermeable upon activation by a medical professional, thereby effectively sequestering the inactivating substance from the medicament and allowing for the intended administration of the medicament to the patient. Unless activated, however, the inactivating substance and medicament remain commingled in the dosage form, and any attempt to dispense the medicament before activation will result in the release of inactivated medicament.
    Type: Application
    Filed: September 20, 2006
    Publication date: February 1, 2007
    Applicant: Euro-Celtique S.A.
    Inventor: Richard Sackler
  • Aryl substituted thiazolidinones and the use thereof
    Patent number: 7169782
    Abstract: This invention relates aryl substituted thiazolidinones of Formula I: or a pharmaceutically acceptable salt, or solvate thereof, wherein R1 and R2, are defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: January 30, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Qun Sun, Donald J. Kyle, Parviz Gharagozloo, Ji Yang
  • Aryl substituted pyridines and the use thereof
    Publication number: 20070010554
    Abstract: This invention relates aryl substituted pyridines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Ar and R1—R4 are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Application
    Filed: September 11, 2006
    Publication date: January 11, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Bin Shao, R. Goehring, Samuel Victory
  • Therapeutic agents useful for treating pain
    Patent number: 7157462
    Abstract: A compound of formula: wherein Ar, Ar1, Ar2, R3–R6, R13, m, and t are disclosed herein, or a pharmaceutically acceptable salt thereof (a “Hydroxyiminopiperazine Compound”); compositions comprising an effective amount of a Hydroxyiminopiperazine Compound; and methods for treating or preventing pain and other conditions in an animal comprising administering to an animal in need thereof an effective amount of a Hydroxyiminopiperazine Compound are disclosed.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: January 2, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Qun Sun, Xiaoming Zhou
  • Pharmaceutical formulation containing irritant
    Patent number: 7157103
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: January 2, 2007
    Assignee: Euro-Celtique S.A.
    Inventor: Richard Sackler
  • Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
    Patent number: 7144587
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and a bittering agent in an effective amount to impart a bitter taste to an abuser upon administration of the dosage form after tampering.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: December 5, 2006
    Assignee: Euro-Celtique S.A.
    Inventors: Benjamin Oshlack, Robert Colucci, Curtis Wright, Christopher Breder
  • Controlled release tramadol formulations
    Publication number: 20060269603
    Abstract: A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
    Type: Application
    Filed: May 16, 2006
    Publication date: November 30, 2006
    Applicant: Euro-Celtique S.A.
    Inventors: Ronald Brown Miller, Stewart Leslie, Sandra Malkowska, Kevin Smith, Walter Wimmer, Horst Winkler, Udo Hahn, Derek Prater
  • Pharmaceutical formulation containing bittering agent
    Patent number: 7141250
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of a bittering agent to impart a bitter taste to an abuser upon administration of said dosage form after tampering.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: November 28, 2006
    Assignee: Euro-Celtique S.A.
    Inventors: Benjamin Oshlack, Robert Colucci, Curtis Wright, Christopher Breder
  • Benzimidazole compounds having nociceptin receptor affinity
    Publication number: 20060264638
    Abstract: Disclosed are compounds of the formula (I) wherein A, R1, R2, R3, R4 and X1 are as disclosed herein. The compounds have affinity for the ORL1 receptor and are useful in the treatment of chronic and acute pain.
    Type: Application
    Filed: July 28, 2006
    Publication date: November 23, 2006
    Applicant: Euro-Celtique S.A.
    Inventors: Donald Kyle, Richard Goehring, Bin Shao
  • Analog scale for measuring pain
    Patent number: D540702
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: April 17, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Stefaan Schatteman, Kris Schellens